EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Comorbidity Assessment in Skin Cancer Patients: A Pilot Study Comparing Medical Interview with a Patient-Reported Questionnaire

Erica H Lee, Rajiv I Nijhawan, Kishwer S Nehal, Stephen W Dusza, Amanda Levine, Amanda Hill, Christopher A Barker

Journal of Skin Cancer · 2015 · 2015 · 1-6

DOI: 10.1155/2015/953479 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Skin Cancer, 2015. Verfasst von Erica H Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10022, USA. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: NCI NIH HHS.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Comorbidities are conditions that occur simultaneously but independently of another disorder. Among skin cancer patients, comorbidities are common and may influence management.

Objective

We compared comorbidity assessment by traditional medical interview (MI) and by standardized patient-reported questionnaire based on the Adult Comorbidity Evaluation-27 (ACE-27).

Methods

Between September 2011 and October 2013, skin cancer patients underwent prospective comorbidity assessment by a Mohs surgeon (MI) and a radiation oncologist (using a standardized patient-reported questionnaire based on the ACE-27, the PRACE-27). Comorbidities were identified and graded according to the ACE-27 and compared for agreement.

Results

Forty-four patients were evaluated. MI and PRACE-27 identified comorbidities in 79.5% and 88.6% ( p = 0.12 ) of patients, respectively. Among 27 comorbid ailments, the MI identified 9.9% as being present, while the PRACE-27 identified 12.5%. When there were discordant observations, PRACE-27 was more likely than MI to identify the comorbidity ( O R = 5.4 , 95% CI = 2.4–14.4, p < 0.001 ). Overall comorbidity scores were moderate or severe in 43.2% (MI) versus 59.1% (PRACE-27) ( p = 0.016 ).

Limitations

Small sample size from a single institution.

Conclusion

Comorbidities are common in skin cancer patients, and a standardized questionnaire may better identify and grade them. More accurate comorbidity assessments may help guide skin cancer management.

Autor:innen und Institutionen

  • Department of Medicine, Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10022, USA.
  • Department of Medicine, Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10022, USA ; Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  • Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Förderung

  • NCI NIH HHS

Zitieren

APA

Lee, E. H., Nijhawan, R. I., Nehal, K. S., Dusza, S. W., Levine, A., Hill, A., & Barker, C. A. (2015). Comorbidity Assessment in Skin Cancer Patients: A Pilot Study Comparing Medical Interview with a Patient-Reported Questionnaire. Journal of Skin Cancer, 2015, 1-6. https://doi.org/10.1155/2015/953479

Vancouver

Lee EH, Nijhawan RI, Nehal KS, Dusza SW, Levine A, Hill A, et al. Comorbidity Assessment in Skin Cancer Patients: A Pilot Study Comparing Medical Interview with a Patient-Reported Questionnaire. Journal of Skin Cancer. 2015;2015:1-6. doi:10.1155/2015/953479

BibTeX
@article{Lee2015,
  author = {Lee, Erica H and Nijhawan, Rajiv I and Nehal, Kishwer S and Dusza, Stephen W and Levine, Amanda and Hill, Amanda and Barker, Christopher A},
  title = {Comorbidity Assessment in Skin Cancer Patients: A Pilot Study Comparing Medical Interview with a Patient-Reported Questionnaire},
  journal = {Journal of Skin Cancer},
  year = {2015},
  volume = {2015},
  pages = {1--6},
  doi = {10.1155/2015/953479}
}
Kostenlos starten →